ATLANTA – An Alcon executive explained the company’s plans to separate its medical device and pharmaceutical businesses, during a company-sponsored press conference here at SECO. Richard E. Weisbarth, OD, FAAO, Alcon vice president of professional affairs, detailed the rationale behind the changes that were announced in January. “Moving to the future, Alcon will focus on the medical device area,” he said.
